Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Berruti

Showing results (71-80 of 150) with videos related to

Pageof 15
Sort By:
Lung Cancer (Amsterdam, Netherlands)|June 1, 1996
Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patientsS Bretti, A Berruti, G Gorzegno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinomaM P Brizzi, C M Sculli, F Ragni, et al.
British Journal of Cancer|November 11, 1999
Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experienceA Berruti, P Borasio, A Gerbino, et al.
Journal of Endocrinological Investigation|April 24, 2012
Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinomaA Ferrero, P Sperone, A Ardito, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Potential clinical value of circulating chromogranin A in patients with prostate carcinomaA Berruti, L Dogliotti, A Mosca, et al.
Cancer Chemotherapy and Pharmacology|March 6, 1998
Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot studyL Dogliotti, S Danese, A Berruti, et al.
Clinical Chemistry|August 3, 1999
Differential patterns of bone turnover in relation to bone pain and disease extent in bone in cancer patients with skeletal metastasesA Berruti, L Dogliotti, G Gorzegno, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Estimation of the Lifetime Quality-Adjusted Life Years (QALYs) Lost Due to Syphilis Acquired in the United States in 2018Kyueun Lee, Shiying You, Yunfei Li, et al.
European Journal of Pain (London, England)|June 21, 2012
Circadian variation of breakthrough pain in cancer patientsA Saini, M Tucci, M Tampellini, et al.
The International Journal of Biological Markers|January 11, 2003
Metabolic effects of single-dose pamidronate administration in prostate cancer patients with bone metastasesA Berruti, L Dogliotti, M Tucci, et al.
Pageof 15

Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
Lung Cancer (Amsterdam, Netherlands)|June 1, 1996
Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patientsS Bretti, A Berruti, G Gorzegno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinomaM P Brizzi, C M Sculli, F Ragni, et al.
British Journal of Cancer|November 11, 1999
Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experienceA Berruti, P Borasio, A Gerbino, et al.
Journal of Endocrinological Investigation|April 24, 2012
Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinomaA Ferrero, P Sperone, A Ardito, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Potential clinical value of circulating chromogranin A in patients with prostate carcinomaA Berruti, L Dogliotti, A Mosca, et al.
Cancer Chemotherapy and Pharmacology|March 6, 1998
Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot studyL Dogliotti, S Danese, A Berruti, et al.
Clinical Chemistry|August 3, 1999
Differential patterns of bone turnover in relation to bone pain and disease extent in bone in cancer patients with skeletal metastasesA Berruti, L Dogliotti, G Gorzegno, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Estimation of the Lifetime Quality-Adjusted Life Years (QALYs) Lost Due to Syphilis Acquired in the United States in 2018Kyueun Lee, Shiying You, Yunfei Li, et al.
European Journal of Pain (London, England)|June 21, 2012
Circadian variation of breakthrough pain in cancer patientsA Saini, M Tucci, M Tampellini, et al.
The International Journal of Biological Markers|January 11, 2003
Metabolic effects of single-dose pamidronate administration in prostate cancer patients with bone metastasesA Berruti, L Dogliotti, M Tucci, et al.
Pageof 15